© 1997 American Heart Association, Inc.
Articles |
Effect of Iron Overload and Iron Deficiency on Atherosclerosis in the Hypercholesterolemic Rabbit
From the Evans Memorial Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass.
Correspondence to Balz Frei, PhD, Linus Pauling Institute, Oregon State University, 571 Weinger Hall, Corvallis, OR 97331. E-mail baiz.frei{at}orst.edu
Abstract It has been suggested that iron plays an important role in the pathogenesis of atherosclerosis, primarily by acting as a catalyst for the atherogenic modification of LDL. Although some epidemiological data suggest that high stored iron levels are an independent risk factor for coronary artery disease and that iron has been detected in both early and advanced atherosclerotic lesions, the evidence is often contradictory and inconclusive. We used the New Zealand White rabbit to investigate the effects of iron overload (FeO) and iron deficiency (FeD) on atherosclerosis. Groups of 7 rabbits were either iron loaded by injections of iron dextran (FeO group), iron depleted by phlebotomy (FeD group), or given injections of saline (control group) for a total of 9 weeks. All rabbits were fed a chow diet containing 1% (wt/wt) cholesterol for the last 6 weeks of the study. Iron and antioxidant status and cholesterol levels were assayed in plasma before cholesterol feeding (week 3) and at the time that the rabbits were killed (week 9). In addition, the susceptibility of LDL to oxidation was measured and pathological examination of the aortic arch and thoracic aorta performed at the end of the study. FeD significantly decreased the levels of blood hemoglobin, serum iron, and transferrin saturation compared with controls. Conversely, FeO significantly increased transferrin Fe saturation. FeO but not FeD decreased plasma cholesterol levels compared with control animals both before (P<.05) and after (P=.055) cholesterol feeding. Neither FeO nor FeD had a significant effect on the levels of antioxidants and lipid peroxidation products in plasma and aortic tissue or on the susceptibility of LDL to ex-vivo oxidation. FeO significantly decreased aortic arch lesion formation by 56% compared with controls (P<.05), whereas FeD had no significant effect. These results indicate that in this animal model, FeO decreases rather than increases atherosclerosis, likely because iron dextran exerts a hypocholesterolemic effect. Our data do not support the hypotheses that elevation of Fe stores increases or that a reduction of Fe stores by phlebotomy decreases the risk of coronary artery disease.
Key Words: LDL • antioxidants • lipid peroxidation • free radicals • metal ions
This article has been cited by other articles:
 |
|
 |
|
  N. Lamharzi, C. B. Renard, F. Kramer, S. Pennathur, J. W. Heinecke, A. Chait, and K. E. Bornfeldt Hyperlipidemia in Concert With Hyperglycemia Stimulates the Proliferation of Macrophages in Atherosclerotic Lesions: Potential Role of Glucose-Oxidized LDL Diabetes, December 1, 2004; 53(12): 3217 - 3225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ramakrishna, T. W Rooke, and L. T Cooper Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light Vascular Medicine, August 1, 2003; 8(3): 203 - 210. [Abstract] [PDF]
|
|
|
|
 |
|
 S. M. Day, D. Duquaine, L. V. Mundada, R. G. Menon, B. V. Khan, S. Rajagopalan, and W. P. Fay Chronic Iron Administration Increases Vascular Oxidative Stress and Accelerates Arterial Thrombosis Circulation, May 27, 2003; 107(20): 2601 - 2606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. L. Turbino-Ribeiro, M. E. Silva, D. A. Chianca Jr, H. de Paula, L. M. Cardoso, E. Colombari, and M. L. Pedrosa Iron Overload in Hypercholesterolemic Rats Affects Iron Homeostasis and Serum Lipids but Not Blood Pressure J. Nutr., January 1, 2003; 133(1): 15 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Choi, S. K. Kim, and S. H. Pai Changes in Serum Lipid Concentrations during Iron Depletion and after Iron Supplementation Ann. Clin. Lab. Sci., April 1, 2001; 31(2): 151 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chen, J. Suh, A. C. Carr, J. D. Morrow, J. Zeind, and B. Frei Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1406 - E1412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. HEINECKE Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall FASEB J, July 1, 1999; 13(10): 1113 - 1120. [Abstract] [Full Text]
|
|
|
|
|
|
D. Pratico, M. Pasin, O. P. Barry, A. Ghiselli, G. Sabatino, L. Iuliano, G. A. FitzGerald, and F. Violi Iron-Dependent Human Platelet Activation and Hydroxyl Radical Formation : Involvement of Protein Kinase C Circulation, June 22, 1999; 99(24): 3118 - 3124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Xing, J. Baffic, and C. P. Sparrow LDL oxidation by activated monocytes: characterization of the oxidized LDL and requirement for transition metal ions J. Lipid Res., November 1, 1998; 39(11): 2201 - 2208. [Abstract] [Full Text]
|
|